Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,8611,880 of 20,252 grants

Active NON-SBIR/STTR RPGS
Modifiable Determinants of Disparities in Multiple Myeloma Treatment Patterns
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT In this K99/R00 Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers application, Dr. Hamlet Gasoyan outlines a detailed prop...

$2.49M
USD
Completed OTHER RESEARCH-RELATED
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2024

Project Summary (as stated in parent grant) Pancreatic ductal adenocarcinoma (PDAC) is a devastating form of pancreatic cancer with dismal patient outcome. KRAS, which is commonly...

$756K
USD
Completed NON-SBIR/STTR RPGS
Functional modeling of race-specific features underlying phenotypic reprogramming in metastatic stem cells from colorectal cancer patients
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY (unchanged from Parent R37) Metastasis causes >90% of cancer death. The persistence and lethality of metastasis is driven by cells capable of self-renewal, slow...

$2.55M
USD
Active NON-SBIR/STTR RPGS
Quantitative analysis and manipulation of chromosome dynamics in cancer organoids
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2027

Project Summary/Abstract Most tumors are not homogeneous, but rather comprised of highly distinct and heterogenous cancer cell populations. Adjacent cells within a tumor may harbor...

$2.27M
USD
Active OTHER RESEARCH-RELATED
Innovative approaches to randomized behavioral clinical trials
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2028

PROJECT SUMMARY This advanced-level short course will provide intensive training in innovative approaches for designing and conducting randomized clinical trials (RCTs) of behavior...

$2.16M
USD
Active NON-SBIR/STTR RPGS
A New Paradigm to Prevent and Treat Micrometastases
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2024 – 2029

Abstract Metastsis is the direct cause of the majority of deaths in patients with solid tumors, thus representing a major unmet medical need. In some cancer types, microscopic meta...

$5.05M
USD
Active NON SBIR/STTR CONTRACTS
TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENT Base IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate E
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2029

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from di...

$35K
USD
Active NON SBIR/STTR CONTRACTS
Contract Orientation and Kickoff Meeting
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic....

$35K
USD
Active NON SBIR/STTR CONTRACTS
TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENTBase IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate End
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from di...

$35K
USD
Active NON SBIR/STTR CONTRACTS
Contract Orientation and Kickoff Meeting
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2024 – 2029

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from di...

$35K
USD
Completed NON SBIR/STTR CONTRACTS
Contract Orientation and Kickoff Meeting
NATIONAL CANCER INSTITUTE Iit Research Institute United States 2024 – 2024

This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structuredapproach to drug and vaccine development, from discovery to the clinic. T...

$93.8K
USD
Active NON SBIR/STTR CONTRACTS
Contract Orientation and Kickoff Meeting
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2024 – 2029

The objective of the “Preclinical PREVENT Cancer Program: Toxicology and Pharmacology Testing” IDIQ contracts will be to continue evaluation of the pharmacological and toxicologica...

$35K
USD
Completed OTHER RESEARCH-RELATED
Tumor Metabolism
NATIONAL CANCER INSTITUTE Keystone Symposia United States 2024 – 2024

ABSTRACT Support is requested for a Keystone Symposia conference entitled Tumor Metabolism, organized by Drs. Gina DeNicola, Rushika Perera and David Shackelford. The conference wi...

$100K
USD
Completed NON-SBIR/STTR RPGS
A multimodal single-cell approach to developing personalized combinatorial treatments for glioblastoma
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2025

A major impediment to the treatment of glioblastoma (GBM) is its extensive intratumoral heterogeneity: Each GBM tumor is heterogeneous with respect to genetics, immune microenviron...

$2.5M
USD
Completed TRAINING, INDIVIDUAL
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2024 – 2025

PROJECT SUMMARY T cell trafficking to tumors represents a critical process in the tumor immunity cycle. However, many tumors can recruit T cells to the tumor, but these T cells are...

$412.9K
USD
Completed OTHER RESEARCH-RELATED
Dietary Control of the Pro-Metastatic Niche in Colorectal Cancer
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2024 – 2025

PROJECT SUMMARY Colorectal cancer (CRC) metastasis is a major cause of mortality, yet there is a distinct lack of therapies targeting metastasis. Among the major modifiable externa...

$1.42M
USD
Active NON-SBIR/STTR RPGS
Integrating patient-reported outcomes and T-cell receptor sequencing to predict immune-related adverse events
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2028

Abstract. This proposal is disease agnostic and patient centered, focusing on symptoms associated with side effects of immune checkpoint inhibitors (ICPis). Although ICPis are effe...

$6.57M
USD
Completed NON-SBIR/STTR RPGS
Developing TCR-T cell therapy in renal cell carcinoma
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2024 – 2025

Abstract T cells play a central role in the anti-cancer immune response. Engineering and administrating tumor-specific T cells have successfully treated some types of cancer. Compa...

$2.2M
USD
Active NON-SBIR/STTR RPGS
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2024 – 2028

The goal of this competitive renewal is to interrogate a paradigm-shifting hypothesis that a combination of CB- 839, a glutaminase inhibitor, and 5-FU induces neutrophil extracellu...

$4.03M
USD
Completed OTHER RESEARCH-RELATED
Breaching the Tumor-Immune Mechanical Barrier for Optimal Antitumor Immunity
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2025

Project Summary/Abstract Tumor immune exclusion predicts poor anticancer therapeutic responses and patient outcomes. The mechanical barrier built by intercellular junction connecti...

$1.76M
USD